236 related articles for article (PubMed ID: 26202636)
1. Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity.
Chen CL; Tsukamoto H; Machida K
Hepatol Int; 2014 Jul; 8(3):330-8. PubMed ID: 26202636
[TBL] [Abstract][Full Text] [Related]
2. TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.
Uthaya Kumar DB; Chen CL; Liu JC; Feldman DE; Sher LS; French S; DiNorcia J; French SW; Naini BV; Junrungsee S; Agopian VG; Zarrinpar A; Machida K
Gastroenterology; 2016 Mar; 150(3):707-19. PubMed ID: 26582088
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K
J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128
[TBL] [Abstract][Full Text] [Related]
4. Tumor-initiating stem-like cells and drug resistance: carcinogenesis through Toll-like receptors, environmental factors, and virus.
Machida K
Drug Deliv Transl Res; 2013 Apr; 3(2):152-64. PubMed ID: 25787983
[TBL] [Abstract][Full Text] [Related]
5. Cell fate, metabolic reprogramming and lncRNA of tumor-initiating stem-like cells induced by alcohol.
Machida K
Chem Biol Interact; 2020 May; 323():109055. PubMed ID: 32171851
[TBL] [Abstract][Full Text] [Related]
6. Alcohol, TLR4-TGF-β antagonism, and liver cancer.
Tsukamoto H; Mishra L; Machida K
Hepatol Int; 2014 Sep; 8 Suppl 2(Suppl 2):408-12. PubMed ID: 26201318
[TBL] [Abstract][Full Text] [Related]
7. TLR4-dependent tumor-initiating stem cell-like cells (TICs) in alcohol-associated hepatocellular carcinogenesis.
Machida K; Feldman DE; Tsukamoto H
Adv Exp Med Biol; 2015; 815():131-44. PubMed ID: 25427905
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus.
Machida K; Chen CL; Liu JC; Kashiwabara C; Feldman D; French SW; Sher L; Hyeongnam JJ; Tsukamoto H
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):19-22. PubMed ID: 22320911
[TBL] [Abstract][Full Text] [Related]
9. NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.
Chen CL; Uthaya Kumar DB; Punj V; Xu J; Sher L; Tahara SM; Hess S; Machida K
Cell Metab; 2016 Jan; 23(1):206-19. PubMed ID: 26724859
[TBL] [Abstract][Full Text] [Related]
10. HCV and tumor-initiating stem-like cells.
Machida K
Front Physiol; 2022; 13():903302. PubMed ID: 36187761
[TBL] [Abstract][Full Text] [Related]
11. NANOG-Dependent Metabolic Reprogramming and Symmetric Division in Tumor-Initiating Stem-like Cells.
Machida K
Adv Exp Med Biol; 2018; 1032():105-113. PubMed ID: 30362094
[TBL] [Abstract][Full Text] [Related]
12. Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?
Machida K
Hepatol Int; 2017 Mar; 11(2):143-147. PubMed ID: 27990610
[TBL] [Abstract][Full Text] [Related]
13. LIN28 and histone H3K4 methylase induce TLR4 to generate tumor-initiating stem-like cells.
Hernandez JC; Chen CL; Machida T; Uthaya Kumar DB; Tahara SM; Montana J; Sher L; Liang J; Jung JU; Tsukamoto H; Machida K
iScience; 2023 Mar; 26(3):106254. PubMed ID: 36949755
[TBL] [Abstract][Full Text] [Related]
14. CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma.
Kakehashi A; Ishii N; Sugihara E; Gi M; Saya H; Wanibuchi H
Cancer Sci; 2016 May; 107(5):609-18. PubMed ID: 26882440
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog.
Machida K; Tsukamoto H; Mkrtchyan H; Duan L; Dynnyk A; Liu HM; Asahina K; Govindarajan S; Ray R; Ou JH; Seki E; Deshaies R; Miyake K; Lai MM
Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1548-53. PubMed ID: 19171902
[TBL] [Abstract][Full Text] [Related]
16. Pluripotency Transcription Factors and Metabolic Reprogramming of Mitochondria in Tumor-Initiating Stem-like Cells.
Machida K
Antioxid Redox Signal; 2018 Apr; 28(11):1080-1089. PubMed ID: 29256636
[No Abstract] [Full Text] [Related]
17. Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor-Initiating Stem-Like Cells.
Chen CL; Hernandez JC; Uthaya Kumar DB; Machida T; Tahara SM; El-Khoueiry A; Li M; Punj V; Swaminathan SK; Kirtane A; Chen Y; Panyam J; Machida K
Adv Sci (Weinh); 2023 May; 10(14):e2206812. PubMed ID: 36949364
[TBL] [Abstract][Full Text] [Related]
18. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
[TBL] [Abstract][Full Text] [Related]
19. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW
Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122
[TBL] [Abstract][Full Text] [Related]
20. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
